Company intelligence / Profile preview

Recor Medical

Palo Alto, California, United Statesrecormedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The Paradise™ Ultrasound Renal Denervation system has demonstrated efficacy and safety for lowering blood pressure in patients with uncontrolled hypertension. It has shown positive results across three independent, randomized, sham-controlled clinical trials. The device received FDA approval in November 2023 as the first ultrasound-based renal denervation therapy for hypertension available in the United States. Clinical data show a significant reduction (~8 mmHg) in systolic blood pressure at two months post-procedure.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically ultrasound-based medical device)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Paradise Ultrasound RDN System

Commercial

Indications: Hypertension

Partnerships

Collaboration with parent company Otsuka Medical Devices for global commercialization and clinical studies

Beyond the preview

Go deeper on Recor Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recor Medical.

Explore the full profile